Study S002774

A Mass Balance Study of [14C] GZR18 in Chinese Overweight or Obese Male Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07119450
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 6
Start: 2025-05-07
Primary completion: 2025-08-13
Lead sponsor: Gan & Lee Pharmaceuticals.
Conditions: Overweight; Obese; Obesity
Interventions: DRUG:GZR18 injection、[14C]GZR18 injection
Results posted: FALSE

Registered primary outcomes

Primary Outcome Measure [Through study completion, an average of 1 year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.